
( (S 
    (NP-SBJ (NNP Immunex) (NNP Corp.) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (PRP$ its) (NNS scientists) )
          (VP (VBD isolated) 
            (NP 
              (NP (DT a) (NN molecule) )
              (SBAR 
                (WHNP-1 (WDT which) )
                (S 
                  (NP-SBJ (-NONE- *T*-1) )
                  (VP (MD may) 
                    (VP (VB hold) 
                      (NP 
                        (NP (JJ potential) )
                        (PP (IN as) 
                          (NP 
                            (NP (DT a) (NN treatment) )
                            (PP (IN for) 
                              (NP 
                                (NP (NNS disruptions) )
                                (PP (IN of) 
                                  (NP (DT the) (NN immune-system) ))
                                (, ,) 
                                (VP (VBG ranging) 
                                  (PP-DIR (IN from) 
                                    (NP (NN organ-transplant) (NN rejection) )
                                    (, ,) )
                                  (PP-DIR (TO to) 
                                    (NP (NNS allergies) 
                                      (CC and)
                                      (NN asthma) )))))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NN molecule) )
    (VP (VBZ is) 
      (NP-PRD 
        (NP (DT the) (NN mouse) (NN version) )
        (PP (IN of) 
          (NP 
            (NP (DT a) (NN protein) )
            (VP (VBN called) 
              (S 
                (NP-SBJ (-NONE- *) )
                (NP-PRD (DT the) (NN interleukin-4) (NN receptor) )))))))
    (. .) ))
( (S 
    (NP-SBJ (NN IL-4) )
    (VP (VBZ is) 
      (NP-PRD 
        (NP (DT a) (NN hormone) )
        (SBAR 
          (WHNP-5 (WDT which) )
          (S 
            (NP-SBJ (-NONE- *T*-5) )
            (VP (VBZ directs) 
              (NP 
                (NP (DT the) (NN growth) 
                  (CC and)
                  (NN function) )
                (PP (IN of) 
                  (NP 
                    (NP (JJ white) (NN blood) (NNS cells) )
                    (VP (VBN involved) 
                      (NP (-NONE- *) )
                      (PP-CLR (IN in) 
                        (NP 
                          (NP (DT the) (NN body) (POS 's) )
                          (JJ immune) (NN response) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (NN IL-4) (NN receptor) )
      (PP-LOC (IN on) 
        (NP 
          (NP (DT the) (NN surface) )
          (PP (IN of) 
            (NP (JJ such) (NNS cells) )))))
    (VP (VBZ receives) 
      (NP 
        (NP (DT the) (NN hormone) (POS 's) )
        (NN message) 
        (S 
          (NP-SBJ (-NONE- *) )
          (VP (TO to) 
            (VP (VB rally) 
              (NP 
                (NP (DT the) (NN body) (POS 's) )
                (NN defense) ))))))
    (. .) ))
( (S (CC But) 
    (PP (IN in) 
      (NP 
        (NP (JJ certain) (NNS conditions) )
        (PP (JJ such) (IN as) 
          (NP 
            (NP (JJ autoimmune) (NNS diseases) )
            (CC and) 
            (NP (NNS allergies) )
            (CC and) 
            (NP (NN transplant) (NN rejection) )))))
    (, ,) 
    (NP-SBJ-1 (NNS doctors) )
    (VP (MD would) 
      (VP (VB like) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB damp) 
              (NP (DT the) (JJ immune) (NN response) )
              (SBAR-PRP (IN so) 
                (S 
                  (NP-SBJ (JJ such) (NNS cells) )
                  (VP (VBP do) (RB n't) 
                    (VP (VB touch) 
                      (PRT (RP off) )
                      (NP 
                        (NP (JJ harmful) (JJ inflammatory) (NNS reactions) )
                        (CC or) 
                        (NP (NN cell) (NN destruction) )))))))))))
    (. .) ))
( (S 
    (S-TPC-1 
      (NP-SBJ 
        (NP (DT A) (JJ soluble) (NN form) )
        (PP (IN of) 
          (NP (DT the) (NN receptor) )))
      (VP (MD might) 
        (VP (VB turn) 
          (PRT (RP off) )
          (NP-PRD 
            (NP (DT a) (JJ specific) (NN part) )
            (PP (IN of) 
              (NP (DT the) (JJ immune) (NN response) )))
          (PP (IN without) 
            (NP (JJ general) (JJ immune) (NN suppression) )))))
    (, ,) 
    (NP-SBJ (DT the) (NN company) )
    (VP (VBD said) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NN IL-4) (NN receptor) )
    (VP (VBZ is) 
      (NP-PRD 
        (NP (CD one) )
        (PP (IN of) 
          (NP 
            (NP (CD five) (JJ such) (NNS receptors) )
            (SBAR 
              (WHNP-2 (-NONE- 0) )
              (S 
                (NP-SBJ-3 (-NONE- *T*-2) )
                (VP (TO to) 
                  (VP (VB be) 
                    (NP (-NONE- *-3) )
                    (VP (VBN developed) 
                      (CC and)
                      (VBN tested) 
                      (PP (IN by) 
                        (NP-LGS 
                          (NP (NNP Receptech) (NNP Corp.) )
                          (, ,) 
                          (NP 
                            (NP (DT a) (NN spinoff) )
                            (PP (IN of) 
                              (NP (NNP Immunex) )))))
                      (, ,) 
                      (PP-MNR (IN through) 
                        (NP (DT a) (VBN proposed) 
                          (ADJP 
                            (QP ($ $) (CD 30) (CD million) )
                            (-NONE- *U*) )
                          (JJ initial) (JJ public) (NN offering) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (NNP Immunex) )
    (VP (MD will) 
      (VP (VB contract) 
        (PP-CLR (IN with) 
          (NP (DT the) (NN spinoff) ))
        (S-PRP 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP (VB provide) 
              (NP 
                (NP (DT the) (NN research) )
                (, ,) 
                (NP (NN development) )
                (CC and) 
                (NP 
                  (NP (JJ initial) (NN testing) )
                  (PP (IN of) 
                    (NP (DT the) (JJ new) (NNS agents) )))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP Immunex) )
    (VP (MD will) 
      (VP (VB have) 
        (NP (DT the) (NN option) 
          (S 
            (NP-SBJ (-NONE- *) )
            (VP (TO to) 
              (VP (VB buy) 
                (PRT (RP back) )
                (NP (NNP Receptech) (NNS shares) )
                (PP-TMP (IN after) 
                  (NP (CD five) (NNS years) ))))))))
    (. .) ))
